Logo

Cancer Biomarkers by S. Nass, H. Moses

Large book cover: Cancer Biomarkers

Cancer Biomarkers
by

Publisher: National Academies Press
ISBN/ASIN: 030910386X
ISBN-13: 9780309103862
Number of pages: 252

Description:
Many cancer patients are diagnosed at a stage in which the cancer is too far advanced to be cured, and most cancer treatments are effective in only a minority of patients undergoing therapy. Thus, there is tremendous opportunity to improve the outcome for people with cancer by enhancing detection and treatment approaches. Biomarkers will be instrumental in making that transition.

Home page url

Download or read it online for free here:
Read online
(online reading)

Similar books

Book cover: Cellular Health Series: CancerCellular Health Series: Cancer
by - M/R Pub
This book provides a summary of the progress of Cellular Health in the battle against several forms of cancer and infectious diseases, as well as other serious diseases. It substantiates the fact that cancer will lose its threat.
(7257 views)
Book cover: Endoplasmic Reticulum and Its Role in Tumor ImmunityEndoplasmic Reticulum and Its Role in Tumor Immunity
by - Frontiers Media SA
The endoplasmic reticulum (ER) is an organelle crucial to many cellular functions and processes. ER has a well-established central role in anti-tumor immunity. Perhaps best characterized is the role of the ER in the processing of antigen peptides.
(976 views)
Book cover: Referral Guidelines for Suspected Cancer in Adults and ChildrenReferral Guidelines for Suspected Cancer in Adults and Children
- Royal College of General Practitioners
The guideline covers twelve groups of cancers: lung, upper gastrointestinal cancers, lower gastrointestinal cancers, breast cancer, gynaecological cancers, urological cancers, haematological cancers, skin cancers, head and neck cancers, etc.
(5008 views)
Book cover: Non-Hodgkin's Lymphoma: Diagnosis and ManagementNon-Hodgkin's Lymphoma: Diagnosis and Management
- National Institute for Health and Care Excellence
This guideline aims to facilitate standardisation of practice in treating non-Hodgkin's lymphoma. But because of the rapid development of new therapies as a result of improved understanding of the disease, continual re-evaluation will be essential.
(2205 views)